One relevant preclinical study on Axl in GC was conducted by Bae et al. [58], who investigated the role of cancer-associated fibroblasts (CAF) in promoting aggressiveness in GC through the Axl signaling pathway. This evidence concerns the gene AXL and gastric cancer.